Solazyme (SZYM) IPO Jumps Higher
Tweet
Share
E-mailGet Alerts SZYM Hot Sheet
Join SI Premium – FREE
The IPO for Solazyme (Nasdaq: SZYM) is open for trading. Shares opened at $20 after pricing 10.975 million shares at $18 per share late last night, above a previously expected range of $15-$17 per share.
The offering is being made through Morgan Stanley, Goldman Sachs, Pacific Crest, Jefferies, and Lazard Capital Markets.
Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils.
The offering is being made through Morgan Stanley, Goldman Sachs, Pacific Crest, Jefferies, and Lazard Capital Markets.
Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Private Credit Fund Caps Redemptions At 5%
- Why this stock remains Barclays’ top EU OEM idea despite sector lag
- Recent stock pullback offers another attractive entry in this stock: analyst
Create E-mail Alert Related Categories
Hot IPOs, Hot List, IPOs, Trader TalkRelated Entities
Morgan Stanley, Jefferies & Co, Lazard, Pacific Crest SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
